These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

173 related items for PubMed ID: 324261

  • 1. Metabolic regulation as a control for lipid disorders. I. Influence of (--)-hydroxycitrate on experimentally induced obesity in the rodent.
    Sullivan C, Triscari J.
    Am J Clin Nutr; 1977 May; 30(5):767-76. PubMed ID: 324261
    [Abstract] [Full Text] [Related]

  • 2. Metabolic regulation as a control for lipid disorders. II. Influence of (--)-hydroxycitrate on genetically and experimentally induced hypertriglyceridemia in the rat.
    Sullivan AC, Triscari J, Spiegel JE.
    Am J Clin Nutr; 1977 May; 30(5):777-84. PubMed ID: 857644
    [Abstract] [Full Text] [Related]

  • 3. Hupolipidemic activity of (--)-hydroxycitrate.
    Hamilton JG, Sullivan AC, Kritchevsky D.
    Lipids; 1977 Jan; 12(1):1-9. PubMed ID: 834114
    [Abstract] [Full Text] [Related]

  • 4. Effect of (-)-hydroxycitrate on development of obesity in the Zucker obese rat.
    Greenwood MR, Cleary MP, Gruen R, Blase D, Stern JS, Triscari J, Sullivan AC.
    Am J Physiol; 1981 Jan; 240(1):E72-8. PubMed ID: 7457600
    [Abstract] [Full Text] [Related]

  • 5. Effects of a new anorectic drug (PM 170) on development of gold thioglucose-induced obesity in mice.
    Massicot F, Falcou R, Heymans F, Godfroid JJ, Apfelbaum M.
    Gen Pharmacol; 1987 Jan; 18(3):249-52. PubMed ID: 3106136
    [Abstract] [Full Text] [Related]

  • 6. Influence of (-)-hydroxycitrate on lipigenesis in chickens and rats.
    Chee H, Romsos DR, Leveille GA.
    J Nutr; 1977 Jan; 107(1):112-9. PubMed ID: 833671
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Evaluation of the Effects and Mechanism of L-Citrulline on Anti-obesity by Appetite Suppression in Obese/Diabetic KK-Ay Mice and High-Fat Diet Fed SD Rats.
    Kudo M, Yoshitomi H, Momoo M, Suguro S, Yamagishi Y, Gao M.
    Biol Pharm Bull; 2017 Jan; 40(4):524-530. PubMed ID: 28381807
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Idalopirdine - a small molecule antagonist of 5-HT6 with therapeutic potential against obesity.
    Dudek M, Marcinkowska M, Bucki A, Olczyk A, Kołaczkowski M.
    Metab Brain Dis; 2015 Dec; 30(6):1487-94. PubMed ID: 26419385
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interaction of leptin and amylin in the long-term maintenance of weight loss in diet-induced obese rats.
    Trevaskis JL, Lei C, Koda JE, Weyer C, Parkes DG, Roth JD.
    Obesity (Silver Spring); 2010 Jan; 18(1):21-6. PubMed ID: 19543217
    [Abstract] [Full Text] [Related]

  • 16. Tesofensine, a novel triple monoamine reuptake inhibitor, induces appetite suppression by indirect stimulation of alpha1 adrenoceptor and dopamine D1 receptor pathways in the diet-induced obese rat.
    Axel AM, Mikkelsen JD, Hansen HH.
    Neuropsychopharmacology; 2010 Jun; 35(7):1464-76. PubMed ID: 20200509
    [Abstract] [Full Text] [Related]

  • 17. Antiobesity effects of the beta-cell hormone amylin in combination with phentermine or sibutramine in diet-induced obese rats.
    Roth JD, Trevaskis JL, Wilson J, Lei C, Athanacio J, Mack C, Kesty NC, Coffey T, Weyer C, Parkes DG.
    Int J Obes (Lond); 2008 Aug; 32(8):1201-10. PubMed ID: 18560368
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. D-Xylose suppresses adipogenesis and regulates lipid metabolism genes in high-fat diet-induced obese mice.
    Lim E, Lim JY, Shin JH, Seok PR, Jung S, Yoo SH, Kim Y.
    Nutr Res; 2015 Jul; 35(7):626-36. PubMed ID: 26088373
    [Abstract] [Full Text] [Related]

  • 20. The triple uptake inhibitor (1R,5S)-(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0] hexane hydrochloride (DOV 21947) reduces body weight and plasma triglycerides in rodent models of diet-induced obesity.
    Tizzano JP, Stribling DS, Perez-Tilve D, Strack A, Frassetto A, Chen RZ, Fong TM, Shearman L, Krieter PA, Tschöp MH, Skolnick P, Basile AS.
    J Pharmacol Exp Ther; 2008 Mar; 324(3):1111-26. PubMed ID: 18089843
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.